eCTD transmissions | Australia

ASPHALION and our partner Extedo® can guide you with Australian submissions. We can support you in a variety of activities.

ASPHALION and our partner Extedo® can guide you with Australian submissions. We can support you in a variety of activities.
January 21, 2022

From 1 November, 2021, the Australian Therapeutic Goods Administration (TGA) begins a staged transition to Electronic Common Technical Document- only for all prescription medicines.

Stage 1 of the transition to eCTD-only has just started for all regulatory submissions in Australia. From this date, the following drug applications must be submitted to the Therapeutic Goods Administration (TGA) using the eCTD:

  • New Chemical Entity Medicine (Type A)
  • New Biological Entity Medicine (Type A)
  • New Biosimilar Medicine (Type A)
  • New Combination Medicine (Type B)

Although the majority of the applications of stage 1 are already provided to TGA within eCTD format, requests for exemptions will be assessed by the TGA on a case-by-case basis.

Have a look at the document here: ASPHALION EXTEDO AUSTRALIA eCTD TRANSMISSIONS

For further information you can contact us at: ectd@asphalion.com

Search News & Events

  • Filter by category

Share

Related news and events

FLYER | Asphalion’s eSubmissions Trainings

The training methodology is mainly online, although it can also be carried out in person as per your request. Training sessions are interactive and can be delivered both in Spanish and English; the number of online attendees is unlimited. Additionally, a training server can be enabled for the attendees to carry out real practical cases.

For further information

If you are interested in our services, or wish to get in touch for a general enquiry, please contact us for more information.

Fill the form and we will contact you as soon as possible.

You can also follow us on:

Schedule a Free Meeting

Schedule here a free 30-minutes meeting with one of our consultants and tell us about your project, challenges or doubts. 

We will be happy to assist you!

Schedule a meeting